ABPI update on the pharmaceutical industry and coronavirus
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to this outbreak.
As part of the health community, pharmaceutical companies want to play as big a role as possible in the response to COVID–19. Richard Torbett
The ABPI has launched a new webpage 'Responding to COVID-19' which provides the industry's view on the outbreak and brings together guidance for member companies.
Richard Torbett, Chief Executive of the ABPI, said:
“As part of the health community, pharmaceutical companies want to play as big a role as possible in the response to COVID–19.
“All companies should make appropriate contingency plans that may be required for further stages of the government's action plan and be prepared for the situation to last many months.
“We are working closely with the Department of Health and the NHS on how our members can best support the Government as plans evolve and adapt to the changing situation.
- COVID 19
Last modified: 20 September 2023
Last reviewed: 20 September 2023